Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumours

15 Sept 2017

Abstract excerpt

// Stefan Naulaerts 1, 2, 3, 4 , Cuong C. Dang 5 and Pedro J. Ballester 1, 2, 3, 4 1 Computational Biology and Drug Design, Cancer Research Center of Marseille, INSERM U1068, Marseille, France 2 Institut Paoli-Calmettes, Marseille, France 3 Aix-Marseille Université, Marseille, France 4 CNRS UMR7258, Marseille, France 5 Faculty of Information Technology, VNU University of Engineering and Technology, Hanoi, Vietnam...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Treatments and Studies
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29228590
DOI: 10.18632/oncotarget.20923

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumoursPMID 29228590Read ↗

Systematic assessment of multi-gene predictors of pan-cancer cell line sensitivity to drugs exploiting gene expression dataSemantic proximity Read ↗

Systematic assessment of multi-gene predictors of pan-cancer cell line sensitivity to drugs exploiting gene expression dataSemantic proximity Read ↗

Drug Sensitivity Prediction From Cell Line-Based Pharmacogenomics Data: Guidelines for Developing Machine Learning ModelsSemantic proximity Read ↗

Integrative Statistical Inferences for Drug Sensitivity Biomarkers in CancerSemantic proximity Read ↗

Systematic identification of pan-cancer single-gene expression biomarkers in drug high-throughput screensSemantic proximity Read ↗

Unearthing New Genomic Markers of Drug Response by Improved Measurement of Discriminative PowerSemantic proximity Read ↗

Machine learning models to predict <i>in vivo</i> drug response via optimal dimensionality reduction of tumour molecular profilesSemantic proximity Read ↗

Single nucleotide and copy number variants of cancer driver genes inform drug response in multiple cancers.Semantic proximity Read ↗

Precision Medicine in Oncology: In Vitro Drug Sensitivity and Resistance Test (DSRT) for Selection of Personalized Anticancer TherapySemantic proximity Read ↗

Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.Semantic proximity Read ↗

Predicting Tumor Response to Drugs based on Gene-Expression Biomarkers of Sensitivity Learned from Cancer Cell LinesSemantic proximity Read ↗

Dr.Paso: Drug response prediction and analysis system for oncology researchSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.